3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Sexuality
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Breast Neoplasms
1
Interventions
Testosterone Propionate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sexual Dysfunctions, Psychological
×
Testosterone Propionate
×
Clear all
NCT00612742
2021-10-29
BLOOM
BioSante Pharmaceuticals
Phase 3
Completed
3,656 enrolled